U.S. BioNTech, Honeywell International, Klaviyo
June 12 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday.
HIGHLIGHTS
* BioNTech SE BNTX.O: JP Morgan raises target price to $94 from $90 |
* Honeywell International Inc HON.O: HSBC raises target price to $235 from $200 |
* Klaviyo Inc KVYO.N: Barclays raises to overweight from equal weight |
* NetApp Inc NTAP.O: Susquehanna raises target price to $155 from $138 |
* Welltower Inc WELL.N: Scotiabank raises target price to $110 from $108 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Academy Sports and Outdoors Inc ASO.O: Evercore ISI cuts target price to $60 from $70 |
* Academy Sports and Outdoors Inc ASO.O: Guggenheim cuts target price to $65 from $75 |
* Academy Sports and Outdoors Inc ASO.O: Jefferies cuts target price to $68 from $81 |
* Academy Sports and Outdoors Inc ASO.O: Morgan Stanley cuts target price to $60 from $65 |
* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts target price to $58 from $82 |
* Academy Sports and Outdoors Inc ASO.O: Telsey Advisory Group cuts PT to $65 from $75 |
* Academy Sports and Outdoors Inc ASO.O: Truist Securities cuts PT to $60 from $73 |
* Academy Sports and Outdoors Inc ASO.O: UBS cuts target price to $58 from $81 |
* Academy Sports and Outdoors Inc ASO.O: UBS cuts to neutral from buy |
* Academy Sports and Outdoors Inc ASO.O: Wedbush cuts target price to $65 from $80 |
* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts target price to $55 from $80 |
* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts to equal weight from overweight |
* Addus Homecare Corp ADUS.O: BofA Global Research resumes coverage with buy rating |
* Addus Homecare Corp ADUS.O: BofA Global Research resumes coverage with price objective $135 |
* Agco Corporation AGCO.N: Oppenheimer cuts target price to $133 from $145 |
* Agree Realty Corp ADC.N: KeyBanc initiates coverage with overweight rating and $68 PT |
* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $72 from $79 |
* Aramark ARMK.N: Oppenheimer raises target price to $39 from $36 |
* Autodesk Inc ADSK.O: Barclays cuts target price to $275 from $310 |
* Autodesk Inc ADSK.O: BMO cuts target price to $254 from $293 |
* Autodesk Inc ADSK.O: Citigroup raises target price to $295 from $286 |
* Autodesk Inc ADSK.O: Deutsche Bank cuts target price to $245 from $265 |
* Autodesk Inc ADSK.O: JP Morgan cuts target price to $245 from $260 |
* Avidity Biosciences Inc RNA.O: Chardan Capital Markets raises PT to $45 from $33 |
* BioNTech SE BNTX.O: JP Morgan raises target price to $94 from $90 |
* Bloom Energy Corp BE.N: RBC raises target price to $15 from $14 |
* Broadstone Net Lease Inc BNL.N: KeyBanc initiates coverage with sector weight rating |
* Brown-Forman Corp BFb.N: Truist Securities cuts target price to $50 from $80 |
* Caseys General Stores Inc CASY.O: RBC raises target price to $361 from $322 |
* Celsius Holdings Inc CELH.O: Morgan Stanley cuts target price to $68 from $75 |
* Celsius Holdings Inc CELH.O: Stifel cuts target price to $85 from $95 |
* Celsius Holdings Inc CELH.O: Wedbush cuts target price to $83 from $85 |
* Clearway Energy Inc CWENa.N: CIBC raises target price to $32 from $31 |
* Comerica Inc CMA.N: RBC cuts target price to $58 from $62 |
* Comerica Inc CMA.N: Truist Securities cuts target price to $55 from $60 |
* Darden Restaurants Inc DRI.N: Morgan Stanley cuts target price to $175 from $180 |
* Darden Restaurants Inc. DRI.N: Morgan Stanley cuts target price to $175.00 from $180.00 |
* Darling Ingredients Inc DAR.N: Citigroup cuts target price to $48 from $50 |
* Darling Ingredients Inc DAR.N: Citigroup raises to buy from neutral |
* DXC Technology Co DXC.N: Susquehanna raises target price to $19 from $15 |
* Element Solutions Inc ESI.N: BMO raises target price to $30 from $28 |
* Element Solutions Inc ESI.N: Mizuho raises target price to $29 from $28 |
* Energy Fuels Inc. UUUU.A: H.C. Wainwright raises target price to $10.75 from $10 |
* Expeditors International of Washington Inc EXPD.N: BofA Global Research raises price objective to $131 from $126 |
* First Solar Inc FSLR.O: Baird raises target price to $344 from $246 |
* First Solar Inc FSLR.O: Oppenheimer raises target price to $325 from $271 |
* Fiserv Inc FI.N: Wells Fargo initiates coverage with overweight rating; PT $180 |
* Fortinet Inc FTNT.O: BofA Global Research removes stock from its US 1 list |
* Funko Inc FNKO.O: D.A. Davidson raises target price to $12 from $10.5 |
* Gamestop Corp GME.N: Wedbush cuts target price to $11 from $13.5 |
* Global Payments Inc GPN.N: Wells Fargo initiates with equal weight rating; PT $100 |
* Haemonetics Corp HAE.N: Needham raises to buy from hold |
* Harley-Davidson Inc HOG.N: Citigroup cuts target price to $34 from $36 |
* Honeywell International Inc HON.O: HSBC raises target price to $235 from $200 |
* Intra-Cellular Therapies Inc ITCI.O: JP Morgan raises target price to $78 from $75 |
* Kinder Morgan Inc KMI.N: UBS raises target price to $24 from $22 |
* Klaviyo Inc KVYO.N: Barclays raises target price to $29 from $25 |
* Klaviyo Inc KVYO.N: Barclays raises to overweight from equal weight |
* Mama'S Creations Inc MAMA.O: Craig-Hallum raises target price to $9 from $8 |
* Manitowoc Company Inc MTW.N: UBS cuts target price to $14.5 from $18 |
* McCormick & Company Inc MKC.N: Citigroup raises target price to $69 from $68 |
* McCormick & Company Inc MKC.N: Citigroup raises to neutral from sell |
* MKS Instruments Inc MKSI.O: TD Cowen raises target price to $160 from $150 |
* Moderna Inc MRNA.O: JP Morgan raises target price to $96 from $85 |
* Moderna Inc MRNA.O: Oppenheimer raises target price to $179 from $163 |
* Monster Beverage Corp MNST.O: Roth MKM cuts target price to $56 from $59 |
* NCR Voyix Corp VYX.N: Stifel initiates coverage With Buy rating; target price $16 |
* NetApp Inc NTAP.O: JP Morgan raises target price to $130 from $125 |
* NetApp Inc NTAP.O: Morgan Stanley raises target price to $127 from $106 |
* NetApp Inc NTAP.O: Stifel raises target price to $138 from $130 |
* NetApp Inc NTAP.O: Susquehanna raises target price to $155 from $138 |
* NetApp Inc NTAP.O: TD Cowen raises target price to $145 from $135 |
* Neurocrine Biosciences Inc NBIX.O: JP Morgan raises target price to $169 from $158 |
* Nextera Energy Inc NEE.N: BMO raises target price to $79 from $78 |
* Nextera Energy Inc NEE.N: Guggenheim raises target price to $83 from $82 |
* Nextera Energy Inc NEE.N: Mizuho cuts to neutral from buy |
* Nextera Energy Inc NEE.N: RBC raises target price to $84 from $74 |
* Nextera Energy Partners LP NEP.N: CIBC raises target price to $35 from $34 |
* Nextera Energy Partners LP NEP.N: Mizuho cuts to neutral from buy |
* Old Dominion Freight Line, Inc. ODFL.O: Barclays cuts target price to $195 from $205 |
* Oracle Corp ORCL.N: Barclays raises target price to $160 from $147 |
* Oracle Corp ORCL.N: Barclays raises target price to $160 from $147 |
* Oracle Corp ORCL.N: Bernstein raises target price to $171 from $159 |
* Oracle Corp ORCL.N: BofA Global Research raises price objective to $155 from $144 |
* Oracle Corp ORCL.N: Evercore ISI raises target price to $160 from $145 |
* Oracle Corp ORCL.N: Guggenheim raises target price to $175 from $150 |
* Oracle Corp ORCL.N: JP Morgan raises target price to $110 from $105 |
* Oracle Corp ORCL.N: Morgan Stanley raises target price to $125 from $115 |
* Oracle Corp ORCL.N: Stifel raises target price to $135 from $120 |
* Oracle Corp ORCL.N: TD Cowen raises target price to $165 from $145 |
* Oracle Corp ORCL.N: UBS raises target price to $160 from $150 |
* Oracle Corporation ORCL.N: Morgan Stanley raises target price to $125.00 from $115.00 |
* Pagerduty, Inc. PD.N: Craig-Hallum raises target price to $30 from $21 |
* Pagerduty, Inc. PD.N: Craig-Hallum raises to buy from hold |
* Pepsico Inc. PEP.O: Barclays cuts target price to $180 from $185 |
* Petmed Express Inc PETS.O: Morgan Stanley cuts target price to $3.5 from $6.5 |
* Procore Technologies Inc PCOR.N: TD Cowen initiates coverage with buy rating; PT $85 |
* Protagonist Therapeutics Inc PTGX.O: JP Morgan raises target price to $39 from $37 |
* Realty Income Corp O.N: KeyBanc initiates coverage with sector weight rating |
* Regeneron Pharmaceuticals Inc REGN.O: RBC raises target price to $1,229 from $1,200 |
* Rockwell Automation Inc ROK.N: Daiwa Capital Markets cuts target price to $295 from $305 |
* Rubrik, Inc. RBRK.N: Barclays raises target price to $42 from $41 |
* Salesforce Inc CRM.N: BofA Global Research removes stock from its US 1 list |
* Sherwin-Williams Co SHW.N: BMO cuts target price to $360 from $377 |
* Skechers USA Inc SKX.N: Wells Fargo initiates coverage with overweight rating |
* Skechers USA Inc SKX.N: Wells Fargo initiates coverage with price target $83 |
* Southwest Airlines Co LUV.N: TD Cowen raises target price to $26 from $25 |
* Springworks Therapeutics Inc SWTX.O: JP Morgan cuts target price to $64 from $77 |
* Teladoc Health Inc TDOC.N: Deutsche Bank cuts target price to $15 from $16 |
* Ultragenyx Pharmaceutical Inc RARE.O: JP Morgan raises target price to $94 from $92 |
* United Therapeutics Corp UTHR.O: Wells Fargo raises target price to $350 from $325 |
* Ventas Inc VTR.N: Scotiabank raises target price to $52 from $51 |
* Vornado Realty Trust VNO.N: BMO cuts target price to $29 from $31 |
* Welltower Inc WELL.N: Scotiabank raises target price to $110 from $108 |
* Zai Lab Ltd ZLAB.O: JP Morgan raises target price to $43 from $38 |
* Ziprecruiter Inc ZIP.N: UBS cuts target price to $11 from $13 |
(Compiled by Bengaluru Newsroom)
</body></html>免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。